Endobronchial Ultrasound Market
The market for Endobronchial Ultrasound was estimated at $871 million in 2024; it is anticipated to increase to $1.69 billion by 2030, with projections indicating growth to around $2.94 billion by 2035.
Report Summary
Market Data
Methodology
Table of Contents
Global Endobronchial Ultrasound Market Outlook
Revenue, 2024
$871M
Forecast, 2034
$2.63B
CAGR, 2025 - 2034
11.7%
The Endobronchial Ultrasound industry revenue is expected to be around $973.1 million in 2025 and expected to showcase growth with 11.7% CAGR between 2025 and 2034. The significant advancement is mainly due to the rise in lung cancer cases and the need for efficient and less invasive diagnostic methods like Endobronchial Ultrasound to meet this demand. This shift is also influenced by the increasing population prone to respiratory illnesses. As well, as technological improvements and increased healthcare spending worldwide that are driving growth in this sector.
Endobronchial Ultrasound represents a groundbreaking instrument that boosts live imaging and biopsy functions notably for peripheral lung abnormalities and mediastinal lymph nodes detection tasks while maintaining its reputation for being minimally invasive with high accuracy levels that lead to prompt and precise diagnoses and reduce patient discomfort significantly These ultrasound procedures are widely used in the identification of respiratory conditions mainly lung cancer but have also witnessed a surge in their utilization for addressing other respiratory system issues, like tuberculosis and sarcoidosis recently.
Market Key Insights
- The Endobronchial Ultrasound market is projected to grow from $871.2 million in 2024 to $2.63 billion in 2034. This represents a CAGR of 11.7%, reflecting rising demand across Lung Cancer Diagnosis and Sarcoidosis Diagnosis.
- Olympus Corporation, Boston Scientific Corporation, Medtronic Plc are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Endobronchial Ultrasound market and are expected to observe the growth CAGR of 8.5% to 12.3% between 2024 and 2030.
- Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 11.2% to 14.6%.
- Transition like Advancements in Imaging Techniques is expected to add $206 million to the Endobronchial Ultrasound market growth by 2030.
- The Endobronchial Ultrasound market is set to add $1.8 billion between 2024 and 2034, with manufacturer targeting Infection Diagnosis & Other Pulmonary Conditions Applications projected to gain a larger market share.
- With
advancements in lung disease diagnostics, and
increased demand for minimally invasive procedures, Endobronchial Ultrasound market to expand 202% between 2024 and 2034.
Opportunities in the Endobronchial Ultrasound
Forming partnerships and working together with technology companies or other healthcare providers can also be a strategy for growth in business success and expansion opportunities, in the healthcare industry.
Growth Opportunities in North America and Asia Pacific
In North America the significant expansion of the Endobronchial Ultrasound sector primarily stems from technology and a rise in using minimally invasive methods to detect lung illnesses. Research and development, in this region are highly forward thinking prompted by innovation and broadening the scope of Endobronchial Ultrasound applications across healthcare and clinical settings. In North America's market scenario there is a competition among industry participants vying for the dominant position. This competitive landscape is largely attributed to the medical infrastructure and flourishing healthcare sector that present lucrative prospects for integrating Endobronchial Ultrasound technology. On the consumer front in this region is the increasing incidence of lung cancer and ailments which necessitate the utilization of reliable diagnostic tools, like Endobronchial Ultrasound Therapy.
In the Asia Pacific region the market for Endobronchial Ultrasound is experiencing growth. Positive government regulations along with partnerships between international medical equipment producers have played a role in this rapid advancement. The region has experienced an increase in the use of invasive diagnostic procedures for lung and respiratory illnesses leading to an increased demand for Endobronchial Ultrasound. There is a growing competition, among market participants each striving to establish their presence in this expanding market. This region has witnessed developments in recent times.
Market Dynamics and Supply Chain
01
Driver: Advancements in Lung Disease Diagnostics, and Global Rise in Lung-related Conditions
The rise of the ultrasound industry is also mainly fueled by improvements in diagnosing lung conditions through innovative methods. This modern bronchoscopy approach has also solidified its role as a tool in detecting lung cancer and other respiratory diseases. These advancements have also increased the need, for ultrasounds significantly and contributed to the growth of this market sector. A critical factor accelerating market expansion is also the increasing prevalence of lung-related conditions worldwide. As per WHO estimates, lung cancer is also one of the most reported cancers, responsible for nearly one in five deaths. As a result, the emphasis on early detection and accurate diagnosis using endobronchial ultrasound systems is also heightening, contributing significantly to the markets growth trajectory.
The trend towards invasive techniques for treating lung diseases has also contributed to the expansion of the endobronchial ultrasound market as well. This method involves a needle aspiration guided by ultrasound and is also popular for its clear benefits compared to older invasive methods. With recovery times and lower infection risks, as key advantages its gaining widespread acceptance and shaping market trends significantly.
02
Restraint: High Equipment and Procedure Costs
Endobronchial Ultrasound is considered a groundbreaking method for detecting lung illnesses; however; its implementation comes with expenses related to equipment and upkeep costs. Although hospitals and clinics with budgets might have access to the sophisticated medical devices required for this interventional pulmonology procedure due to their high prices making them inaccessible, to some institutions. Moreover; the specialized nature of the process demands handling which further increases the overall costs. These factors together form an obstacle that could hinder the widespread adoption of Endobronchial Ultrasound in the market.
03
Opportunity: Technological Innovations and Expansion in Emerging Markets
The rise of technologies like advanced imaging methods and AI presents promising opportunities for growth in various industries. By integrating these advancements into ultrasound procedures to enhance diagnostic precision could lead to an increased demand, for these tools. Customizing upgrades to meet the changing demands of the healthcare sector may also contribute to the expansion of the endobronchial ultrasound field.
In countries such as India, China and Brazil where healthcare infrastructure is expanding the Endobronchial Ultrasound market finds conditions to thrive. These nations are experiencing a rise in healthcare expenditure continuous technological progress and an increase in the incidence of lung related illnesses. Seizing opportunities in these developing markets could lead to expansion, for providers of endobronchial ultrasound services.
04
Challenge: Lack of Skilled Professionals
A critical factor constraining the market growth of Endobronchial Ultrasound is the shortage of competent physicians and technicians trained in the procedure. The operation of the sophisticated tools and execution of the intricate ultrasound procedure demand a high level of precision and technical know-how, which, unfortunately, not only all healthcare professionals possess.
Supply Chain Landscape
1
Component Manufacturing
Olympus CorporationBoston Scientific Corporation
2
Device Assembly
MedtronicCook Medical
3
Distribution & Sales
Teleflex IncorporatedConmed Corporation
4
End Users
HospitalsDiagnostic CentersResearch Institutions
1
Component Manufacturing
Olympus CorporationBoston Scientific Corporation
2
Device Assembly
MedtronicCook Medical
3
Distribution & Sales
Teleflex IncorporatedConmed Corporation
4
End Users
HospitalsDiagnostic CentersResearch Institutions
Use Cases of Endobronchial Ultrasound in Lung Cancer Diagnosis & Sarcoidosis Diagnosis
Lung Cancer Diagnosis : Among the most common applications of Endobronchial Ultrasound is in diagnosing lung cancer. The EBUS-TBNA is the most frequently utilized variant in this specific scenario. Physicians employ this procedure to achieve real-time imaging and sampling of lymph nodes and masses within the lungs proximity. The advantages of EBUS-TBNA in this context include a high sensitivity rate, minimal invasiveness, and an effective reduction in the need for surgical staging. Medtronic and Olympus Corporation are among the top players in this sector, with both offering superior technology and market-leading position
Sarcoidosis Diagnosis : Sarcoidosis is another condition where Endobronchial Ultrasound plays a pivotal role. Here, EBUS is used to sample mediastinal and hilar lymph nodes, offering a less invasive alternative to traditional surgical methods like mediastinoscopy. Similar to its usage in lung cancer diagnosis, EBUS-TBNA is the standard technique applied here, allowing physicians to make an accurate diagnosis with decreased patient discomfort and risk. In line with its growing relevance in Advanced Cancer Diagnostics, Olympus Corporation and Boston Scientific are two major companies that hold a strong position in the application of EBUS for sarcoidosis diagnosis.
Recent Developments
The recent advancements in the global healthcare system have driven significant interest toward Endobronchial Ultrasound , a minimally invasive procedure growing in use across the globe. Therapeutic implications and the added advantage of biopsies are contributing factors for its rising popularity.
December 2024 : Medtronics launch of their latest generation of Endobronchial Ultrasound, introducing innovative imaging features and increased patient comfort parameters
November 2024 : Boston Scientifics initiation of a global clinical trial to test the safety and efficacy of their Endobronchial Ultrasound technology in previously unreached patient populations
October 2024 : Olympus Corporations acquisition of a medical start-up specializing in lung diagnostics, showing intent to consolidate their position in the Endobronchial Ultrasound market.
Impact of Industry Transitions on the Endobronchial Ultrasound Market
As a core segment of the Medical Device industry,
the Endobronchial Ultrasound market develops in line with broader industry shifts.
Over recent years, transitions such as Advancements in Imaging Techniques and Teleultrasound Development have redefined priorities
across the Medical Device sector,
influencing how the Endobronchial Ultrasound market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
Advancements in Imaging Techniques
Technological progress has greatly impacted industries in a positive way over time. A prime example being the advancements observed in endobronchial ultrasound technology sector which has seen notable changes recently. In this context powered by cutting edge imaging methods have significantly enhanced the processes related to lung diseases and cancer treatments. This progress has proven advantageous for medical practitioners as it boosts their capacity to spot and address ailments at earlier stages resulting in better outcomes, for patients. By implementing these sophisticated techniques healthcare experts can produce images and administer precise treatment options thereby transforming the field extensively.
02
Teleultrasound Development
The ever-evolving field of telemedicine has spurred growth in the development of teleultrasound in endobronchial applications. This transition has allowed for the remote consultation within the medical field, ensuring that patients in even the most remote locations can access specialist services. It has not only impacted the healthcare industry by improving accessibility, but also transformed the way medical services are delivered.